Shares of SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) fell 1.2% during trading on Tuesday. The company traded as low as $24.38 and last traded at $24.38. 200 shares traded hands during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Price Performance
The firm’s fifty day simple moving average is $24.38 and its 200 day simple moving average is $24.38. The company has a market capitalization of $6.64 billion, a price-to-earnings ratio of 48.76, a PEG ratio of 1.30 and a beta of 1.81.
SWEDISH ORPHAN/S Company Profile
Swedish Orphan Biovitrum AB, known as Sobi, is a Sweden-based biopharmaceutical company focused on developing, manufacturing and commercializing specialty medicines for rare diseases. Its principal areas of activity include hematology, immunology and other conditions in which treatment options are limited or unmet medical needs remain significant.
The company’s portfolio includes therapies for disorders such as hemophilia and other bleeding conditions, as well as treatments for immune-mediated diseases and selected rare inflammatory conditions.
Recommended Stories
- Five stocks we like better than SWEDISH ORPHAN/S
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
